Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
141 studies found for:    Open Studies | "Ascorbic Acid"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Ascorbic Acid"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer
Condition: Fatigue
Interventions: Drug: Ascorbic Acid;   Other: Normal Saline
2 Unknown  Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity
Condition: Drug Safety
Interventions: Drug: Colistin;   Drug: Colistin + Ascorbic acid
3 Recruiting Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
Conditions: Glioblastoma;   Glioma
Interventions: Dietary Supplement: Ascorbic Acid;   Biological: Bevacizumab;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
4 Not yet recruiting Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Dietary Supplement: Ascorbic Acid;   Drug: Docetaxel;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Other: Placebo;   Other: Quality-of-Life Assessment
5 Not yet recruiting Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery
Conditions: Pancreatic Adenocarcinoma;   Recurrent Pancreatic Carcinoma;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer;   Unresectable Pancreatic Carcinoma
Interventions: Drug: Oxaliplatin;   Drug: Irinotecan Hydrochloride;   Drug: Leucovorin Calcium;   Drug: Fluorouracil;   Dietary Supplement: Ascorbic Acid
6 Recruiting Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers
Condition: Oral Mucositis
Interventions: Drug: Ascorbic Acid;   Drug: Multivitamin supplements other than vitamin c
7 Not yet recruiting High Dose Vitamin C in Cardiac Surgery Patients
Conditions: Disorder of Vitamin C;   Atrial Fibrillation;   Complications Due to Coronary Artery Bypass Graft;   Heart Valve Disease
Interventions: Drug: Ascorbic Acid;   Drug: Placebo
8 Unknown  Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma
Condition: Uterine Leiomyoma
Intervention: Drug: ascorbic acid
9 Unknown  Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patiens
Conditions: Anaemia Response to the Treatment;   Peripheral Iron Indices;   Oxalemia
Intervention: Drug: Ascorbic Acid
10 Unknown  The Effect of Vitamin c on Preventing Complex Regional Pain Syndrome (CRPS Type I) Following Ankle Fracture
Condition: Ankle Fracture
Interventions: Dietary Supplement: vitamin c;   Drug: placebo
11 Not yet recruiting Vitamin C for Severe Thermal Injuries
Condition: Severe Thermal Injury, Greater Than 20% TBSA
Interventions: Drug: Vitamin C;   Drug: Placebo
12 Recruiting Treatment of Reperfusion Event by Vitamin C Infusion
Condition: Angina Pectoris
Interventions: Drug: Vitamin C;   Drug: Placebo
13 Unknown  Role of Vitamin C to Augment Iron Chelation With DFP or DFX
Conditions: Vitamin c;   Thalassemia Major;   Iron Chelation
Interventions: Drug: Vitamin C, Defriprone, deferisarox;   Drug: deferiprone , deferesarox
14 Recruiting Effectiveness of Ascorbic Acid and Tocopherol for Depression in Elderly.
Condition: Depression
Interventions: Drug: Ascorbic Acid;   Drug: Alpha tocopherol;   Drug: PLACEBO
15 Unknown  High-dose Ascorbic Acid Intravenous Injection Decreases Mitochondrial DNA Damage in Chronic Fatigue Patients: Randomized-controlled Study
Condition: Chronic Fatigue
Interventions: Drug: ascorbic acid 10g/20ml;   Drug: Normal Saline 150ml
16 Recruiting Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: G-FLIP;   Drug: G-FLIP-DM;   Dietary Supplement: Vitamin C
17 Recruiting Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer
Interventions: Drug: vitamin C;   Device: Modulated Electro-Hyperthermia (mEHT);   Other: Supportive care
18 Not yet recruiting Antioxidants Combined With Cryotherapy on Inflammatory Response After Resistance Exercise in Untrained Volunteers
Conditions: Inflammation;   Oxidative Stress;   Pain
Interventions: Other: Cryotherapy;   Other: Vitamins C and E;   Other: Vitamins C and E associated with cryotherapy;   Other: Placebo
19 Recruiting Pharmacokinetics of Two Different High-dose Regimens of Intravenous Vitamin C in Critically Ill Patients
Conditions: Multiple Organ Failure;   Sepsis;   Systemic Inflammatory Response Syndrome;   Trauma
Intervention: Drug: Ascorbic Acid
20 Not yet recruiting Iron Bioavailability From Encapsulated Ferrous Sulphate
Condition: Iron Deficiency
Interventions: Dietary Supplement: non-encapsulated FeSO4;   Dietary Supplement: encapsulated FeSO4, before cooking;   Dietary Supplement: encapsulated FeSO4, after cooking;   Dietary Supplement: non-encapsulated FeSO4 + ascorbic acid;   Dietary Supplement: encapsulated FeSO4 + ascorbic acid, before cooking;   Dietary Supplement: encapsulated FeSO4 + ascorbic acid, after cooking

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years